Sun Pharma shares dip 2% on forensic audit of books
The scrip declined 1.63 per cent to close at Rs 424.90 on the BSE.
By PTI |
Shares of Sun Pharmaceutical Industries on Friday fell nearly 2 per cent after the firm said a forensic audit has been ordered by markets regulator Sebi with regard to its financial statements.
The scrip declined 1.63 per cent to close at Rs 424.90 on the BSE. During the day, it dropped 4 per cent to Rs 414.60.
On the National Stock Exchange, shares fell 1.57 per cent to close at Rs 425 apiece.
In a regulatory filing on Thursday, Sun Pharma said, "A forensic audit has been ordered by Sebi w.r.t. the financial statements of Sun Pharmaceutical Industries for the financial years ending March 31, 2016, March 31, 2017 and March 31, 2018".
Sun Pharma, however, did not provide any specific details on the reasons for the Securities and Exchange Board of India to order the forensic audit.
A forensic audit is an examination and evaluation of a firm's or individual's financial records to derive evidence that can be used in a court of law or legal proceeding.
The scrip declined 1.63 per cent to close at Rs 424.90 on the BSE. During the day, it dropped 4 per cent to Rs 414.60.
On the National Stock Exchange, shares fell 1.57 per cent to close at Rs 425 apiece.
In a regulatory filing on Thursday, Sun Pharma said, "A forensic audit has been ordered by Sebi w.r.t. the financial statements of Sun Pharmaceutical Industries for the financial years ending March 31, 2016, March 31, 2017 and March 31, 2018".
Sun Pharma, however, did not provide any specific details on the reasons for the Securities and Exchange Board of India to order the forensic audit.
A forensic audit is an examination and evaluation of a firm's or individual's financial records to derive evidence that can be used in a court of law or legal proceeding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
